HUTCHMED (LON:HCM) Shares Pass Below Two Hundred Day Moving Average – Should You Sell?

HUTCHMED (China) Limited (LON:HCM) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 279.53 ($3.52) and traded as low as GBX 227 ($2.86). HUTCHMED shares last traded at GBX 232 ($2.92), with a volume of 59,463 shares trading hands.

HUTCHMED Stock Down 4.1 %

The company has a market capitalization of £1.98 billion, a PE ratio of -5,800.00 and a beta of 0.76. The firm has a fifty day simple moving average of GBX 273.70 and a 200-day simple moving average of GBX 279.53. The company has a debt-to-equity ratio of 11.78, a quick ratio of 2.97 and a current ratio of 2.81.

HUTCHMED Company Profile

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally. The company develops Savolitinib for the treatment of non-small cell lung cancer (NSCLC), papillary renal cell carcinoma (RCC), and gastric cancer (GC); and Fruquintinib, an inhibitor for colorectal cancer (CRC), breast cancer, gastric cancer, microsatellite stable-CRC endometrial cancer (EMC), NSCLC, RCC, gastrointestinal, cervical, and solid tumors.